VACCINES FOR TRAVELERS - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

VACCINES FOR TRAVELERS

Description:

vaccines for travelers – PowerPoint PPT presentation

Number of Views:77
Avg rating:3.0/5.0
Slides: 18
Provided by: PRESENTA174
Category:

less

Transcript and Presenter's Notes

Title: VACCINES FOR TRAVELERS


1
VACCINES FOR TRAVELERS
2
Vaccines for the traveler
  • Reduce the risk of vaccine preventable diseases
    for the individual traveler
  • Reduce the risk of international transmission of
    diseases, and reintroduction of diseases into
    countries
  • Moderate risk Hepatitis A 20cases/1000
    travelers per month
  • Low risk Polio 20/1 000 000 unimmunized
    travelers, Japanese encephalitis lt1/1 000 000
    travelers

3
Factors affecting disease risk and choice of
vaccines in travelers
  • Destination, duration of travel, nature and
    conditions of travel, occurrence of outbreaks
  • Category of traveler leisure and pleasure,
    business, luxury or adventure, refugee, combat
  • Vaccines officially required for entry, vaccines
    dependent on disease risk
  • Person factors immunization/disease history,
    age, allergies, co-morbid disease
  • Costs, time available pretravel

4
Travel vaccines
  • Yellow fever
  • Hepatitis A B
  • Typhoid
  • Cholera
  • Meningococcal disease
  • Diphtheria
  • Polio
  • Rabies
  • Japanese encephalitis
  • European tick borne encephalitis
  • Influenza
  • Measles
  • Tetanus
  • BCG

5
Yellow fever vaccine
  • Attenuated 17 D strain prepared in chick embryos
  • International Health Regulations compulsory
    vaccine for travel to endemic countries or
    persons returning from an endemic area to a
    potentially receptive non-endemic area
  • Administered in licensed yellow fever centres
  • Administer 10 days before travel, durationgt10
    years
  • Little risk of yellow fever to travelers

6
  • Yellow fever maps
  • Yellow fever in tourists

7
Yellow fever vaccine
  • C/I egg allergy, immunosuppression including
    symptomatic HIV, pregnancy, children lt 6 months
  • ADR YF vaccine-associated neurologic disease, YF
    vaccine-associated viscerotropic disease
  • Yellow fever in travelers-
  • Chan Lancet 2001, Martin Lancet 2001

8
Hepatitis A vaccine
  • Commonest vaccine preventable travel infection
  • gt95 protection 4 weeks after first dose
  • Vaccine versus immunoglobulin?
  • Testing for immunity pre vaccination?

9
Polio vaccine
  • Low risk in travelers
  • Single dose for travelers to high risk areas
  • OPV v IPV

10
Rabies vaccine
  • Generally low risk, area dependent
  • 1,882 European travelers in Thailand dog bites
    in 1.3, dog licks in 8.9 in lt 3 weeks
    (Steffan)
  • UK 10 /12 cases over 20 years imported from
    India
  • USA over 17yrs, 33 were imported
  • CDC

11
Rabies vaccine
  • Pretravel rabies vaccine obviates need for
    (scarce) rabies immunoglobulin in high risk
    exposure
  • Indications consider mode of travel, area of
    travel, local rabies epidemiology, access to safe
    and effective post exposure prophylaxis
  • Pre exposure vaccine IMI on days 0, 7 and 28
  • Post exposure give boosters on days 0, 3 and
    omit immunoglobulin
  • Some antimalarials suppress immune response to
    rabies vaccine

12
Typhoid vaccines
  • Live oral vaccine Ty21a strain, schedule of 4
    doses on alternate days
  • Efficacy 63 for 3 years in trials in endemic
    areas. No studies in travelers
  • Polysaccharide vaccine Typhim Vi
  • Efficacy 72-80 in Nepal, in South Africa
  • Indications selected travelers to high risk
    areas
  • Acharya NEJM 1987 Klugman Lancet 1987

13
Cholera vaccine
  • Dukoral? inactivated oral vaccine
  • Protects against Vibrio cholerae 01 and ETEC
  • Cholera protective efficacy 80-85 for 6
    months, and 63 over 3 years
  • ETEC protective efficacy about 60, lasting
    about 3 months
  • Indication Travelers to high risk destinations ?

BASRA, IRAQ 2004
14
Meningococcal vaccine
  • Polysaccharide vaccine A,C,W135,Y AC
  • Single dose
  • 3 yrs protection
  • Indications travelers to the Hajj
  • Travelers to countries in meningitis belt
    experiencing outbreaks

15
Immunization of immunocompromisedtravelers
  • Increased risk of travel related disease
  • Potential risk from live vaccines
  • Potential increase in adverse reactions
  • Decreased vaccine immunogenicity
  • Effect on HIV replication

16
Vaccine schedules
  • Yellow fever and cholera must be given at least
    3 weeks apart
  • Inactivated vaccines and live vaccines can be
    given simultaneously
  • Antibody responses to live vaccines reduced if
    given with immunoglobulin give live vaccines
    either 2 weeks before or minimum of 6 months
    (ideally 3 months) after immunoglobulin

17
The impossible traveler
  • 34 year old security worker on contract to Iraq
  • Request for smallpox vaccine..
Write a Comment
User Comments (0)
About PowerShow.com